Abstract
Purpose. A cytotoxicity assay using a three-dimensional cultured human skin model, Living Skin Equivalent-high (LSE-high) was evaluated as an alternative to the Draize skin irritation tests using animals. A relation between the cytotoxicity and calculated concentration of an irritant in skin was also evaluated.
Methods. Colorimetric thiazoyl blue (MTT) conversion assay and a surfactant, cetylpyridinium chloride (CPC), were selected as a cytotoxicity assay and a model irritant. The fraction of dead cell number in the MTT assay or the Draize irritation score (in vitro and in vivo irritation data, respectively) was treated as a function of CPC concentration in the viable skin of LSE-high and guinea pig. Separately, in vitro permeations of CPC through the LSE-high or excised guinea pig skin were determined to calculate the average concentration of CPC in the viable skin using the Fickian diffusion theory. The obtained relations between the irritation scores and CPC concentration were evaluated by the Emax model (Hill equation).
Results. CPC concentration showing 50% irritation (IC 50) was similar for the MTT assay (18.9%) and Draize test (12.3%), and a good relationship (r = 0.981) was observed between the fraction of dead cell number and the Draize score. In contrast, IC 50, 1.32%, for the MTT assay in LSE-high was much lower than that using guinea pig skin. We then corrected the results for the MTT assay using a ratio of IC 50 in guinea pig skin against LSE-high, resulting in a good relation between both MTT results in guinea pig skin and LSE-high.
Conclusion. The present results suggest that the MTT assay using LSE-high may be utilized as an alternative for the Draize test in animals for evaluating skin irritation.
Similar content being viewed by others
REFERENCES
G. S. Arra, S. Arutla, and D. R. Krishna. Transdermal delivery of isosorbide 5-mononitrate from a new membrane reservoir and matrix-type patches. Drug.Dev.Ind.Pharm. 24:489–492 (1998).
B. W. Barry. Lipid-protein-partitioning theory of skin penetration enhancement. J.Control.Release 15:237–248 (1991).
S. Numajiri, K. Sugibayashi, and Y. Morimoto. Analysis of in vitro iontophoretic skin permeation of sodium benzoate by transport numbers of drug and additives. Chem.Pharm.Bull. 44:1351–1356 (1996).
K. Sugibayashi, M. Yoshida, K. Mori, T. Watanabe, and T. Hasegawa. Electric field analysis on the improved skin concentration of benzoate by electroporation. Int.J.Pharm. 21:107–112 (2001).
J. N. Lawrence. Application of in vitro human skin model to dermal irritancy: a brief overview and future prospects. Toxicol.In Vitro 11:305–312 (1997).
B. J. Nickoloff and Y. Naidu. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J.Am.Acad.Dermatol. 30:535–546 (1994).
J. H. Draize, G. Woodard, and H. O. Galvery. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J.Pharmacol.Exp.Ther. 82: 377–390 (1944).
H. C. Eun and D. H. Suh. Comprehensive outlook of in vitro tests for assessing skin irritancy as alternatives to Draize tests. J.Dermatol.Sci. 24:77–91 (2000).
E. Bell, H. P. Ehrlich, D. J. Buttle, and T. Nakatsuji. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 6:1052–1054 (1981).
M. Chamberlain and L. Earl. Use of cell cultures in irritancy testing. In: A. Rougire, A. M. Goldberg, and H. I. Maibach (eds.), In vitro skin toxicology. Mary Ann Liebert, Inc., NewYork, 1994, pp. 59–67.
P. Maria and K. Johanna. Use of skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacol. 8:49–59 (1995).
M. Shibata, T. Tsuda, H. Itagaki, S. Kato, T. Kobayashi, H. Ishikawa, and Y. Morikawa. Interleukin-1α and interleukin-8 release by human keratinocyte cell culture treated with surfactants. ATLA 25:161–171 (1997).
R. Gay, M. Swiderek, D. Nelson and A. Ernesti. The living skin equivalent as a model in vitro for ranking the toxic potentital of dermal irritants. Toxicol.In Vitro 6: 303–315 (1992).
C. L. Cannon, P. J. Neal, J. A. Soutee, J. Kubilus, and M. Klausner. New epidermal model for dermal irritancy testig. Toxicol.In Vitro 8: 889–891 (1994).
K. Morota, N. Morikawa, S. Morita, H. Kojima, and H. Konishi. Alternative to primary Draize skin irritation test using cultured human skin model: Comparison of six endpoints. Alter.Animal Test.Experiment. 6:41–51 (1999).
K. Sato, K. Sugibayashi, and Y. Morimoto. Species differences in percutaneous absorption of nicorandil. J.Pharm.Sci. 80:104–107 (1991).
M. A. Perkinks, R. Osborne, F. R. Rana, A. Ghassemi, and M. K. Robinson. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. Toxicol.Sci. 48:218–229 (1999).
F. J. Koschier, R. Roth, T. J. Stephens, E. T. Spence, and M. A. Duke. In vitro skin irritation testing of petroleum-based compounds in reconstituted human skin models. J.Toxicol.Cutan.Ocul.Toxicol. 13:23–37 (1994).
K. Tsueda, P. J. Mosca, M. F. Heine, G.E. Loyd, D. A. Durkis, A. L. Malkani, and H. E. Hurst. Mood during epidermal patientcontrolled analgesia with morphine or fentanyl. Anesthesiology 88:885–891 (1998).
M. Washitake, T. Yajima, T. Anmo, T. Arita, and R. Hori. Studies on percutaneous absorption of drugs. 3. Percutaneous absorption of drugs through damaged skin. Chem.Pharm.Bull. 21:2444–2451 (1973).
T. Watanabe, T. Hasegawa, H. Takahashi, T. Ishibashi, K. Takayama, and K. Sugibayashi. Utility of three-dimensional cultured human skin model as a tool to evaluate skin permeation of drugs. Altern.Animal Test.Experiment. 7:1–14 (2001).
J. P. Skelly, V. P. Shah, H. I. Maibach, R. H. Guy, R. C. Wester, G. Flynn, and A. Yacobi. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous permeation studies, relevance to bioavailability and bioeqivalence. Pharm.Res. 4:265–267 (1987).
M. Okumura, K. Sugibayashi, K. Ogawa, and Y. Morimoto. Skin permeability of water-soluble drugs. Chem.Pharm.Bull. 37: 1404–1406 (1989).
D. Nelson and R. J. Gay. Effects of UV irradiation on a living skin equivalent. Photochem.Photobiol. 57:830–837 (1993).
F. T. Slater, B. Sawyer, and U. Strauli. Studies on succinaetetrazolium reductase systems. 3. Points of coupling four different tetrazolium salts. Biochim.Biophys.Acta 77:383–393 (1963).
T. Mosmann. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J.Immunol.Methods 65:55–63 (1983).
K. Sugibayashi, T. Watanabe, T. Hasegawa, H. Takahashi, and T. Ishibashi. Kinetic analysis on the in vitro cytotoxicity using living skin equivalent for ranking the potential of dermal irritants. Toxicol.In Vitro. Submitted.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Watanabe, T., Hasegawa, T., Takahashi, H. et al. Utility of MTT Assay in Three-Dimensional Cultured Human Skin Model as an Alternative for Draize Skin Irritation Test: Approach Using Diffusion Law of Irritant in Skin and Toxicokinetics-Toxicodynamics Correlation. Pharm Res 19, 669–675 (2002). https://doi.org/10.1023/A:1015366331634
Issue Date:
DOI: https://doi.org/10.1023/A:1015366331634